Food is Medicine (FIM) interventions are designed to help manage diet-sensitive diseases. Despite their popularity, it is unclear whether FIM programs significantly impact nutritional and clinical outcomes among adults with type 2 diabetes (T2DM), a highly prevalent chronic disease in the U.S. To evaluate FIM programs focused on diabetes management, dietary intake, and food security outcomes among adults with T2DM. A systematic search was completed in September 2025. Eligible studies were in English and conducted in the U.S. FIM interventions provided food or increased access to food. Study assessments included diabetes outcomes, diet, and food security. Risk of bias was evaluated. Twenty-three studies were included (21 quantitative, 1 qualitative, 1 mixed methods). Nine of 21 quantitative studies observed statistically significant reductions in hemoglobin A1c (-0.1% to -3.0%), however, only two were clinically significant improvements. Improved dietary habits were observed in 14 of 19 studies assessing vegetable and fruit intake (+0.2 to +0.9 mean servings/day) and four of six studies assessing diet quality (+0.04 to +31.8 points). Eight of ten studies found significant reductions in food insecurity (-8.9% to -53.5%). Qualitative studies suggested perceived improvement in diet quality, food security, and diabetes management by participants. Risk of bias was ‘fair’ for most studies. Modest improvements in dietary intake, food security status, and diabetes management were observed in 43% of studies; however, most were not clinically significant changes. The low rigor of many studies suggests caution against drawing conclusions regarding FIM program efficacy. This review was registered on Prospero (PROSPERO 2021 CRD42021284000) and supported in part by National Institutes of Health (R01DK132300).
Martin et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: